Literature DB >> 19040292

Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals.

Serena Delbue1, Emanuela Branchetti, Renzo Boldorini, Luca Vago, Pietro Zerbi, Claudia Veggiani, Sara Tremolada, Pasquale Ferrante.   

Abstract

JC virus (JCV) is a polyomavirus that asymptomatically infects up to 80% of the worldwide human population and establishes latency in the kidney. In the case of host immunodeficiency, it can cause progressive multifocal leukoencephalopathy (PML), which is a fatal demyelinating disease of the central nervous system. In an attempt to understand better PML pathogenesis and JCV infection, the presence of the JCV genome and expression of the early viral protein in the brain of deceased individuals, with and without HIV infection, was investigated. Sixty autopsy samples of brain tissues were collected from 15 HIV-positive PML patients, 15 HIV-positive patients with other neurological diseases, 15 HIV-positive patients without neurological disorders, and 15 HIV-negative individuals who died from diseases unrelated to the central nervous system. By means of specific Real Time Polymerase Chain Reaction, the JCV genome was detected in 14 of 15 PML brains, three of 15 HIV-positive brains (with and without neurological diseases), and 1 of 15 HIV-negative brains. JCV genotyping was also performed. Expression of the early JCV protein T Antigen was verified by a specific immunohistochemistry assay, and it was found in the brain tissues from 12 PML cases and one case with other neurological disease. The data obtained demonstrate that infection of the brain with JCV can also be observed in the brains of HIV-negative individuals, without neurological disorders. However, viral protein expression was limited to PML brains and to one brain from a patient with other neurological disease, suggesting that JCV can also be present in the brains of patients without PML.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19040292      PMCID: PMC2597165          DOI: 10.1002/jmv.21313

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  27 in total

1.  Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients.

Authors:  P Ferrante; M Mediati; R Caldarelli-Stefano; L Losciale; R Mancuso; A E Cagni; R Maserati
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

Review 2.  Natalizumab. Elan/Biogen.

Authors:  Mariano J Elices
Journal:  Curr Opin Investig Drugs       Date:  2003-11

3.  JC virus detection by in situ hybridization in brain tissue from elderly patients.

Authors:  M Mori; H Kurata; M Tajima; H Shimada
Journal:  Ann Neurol       Date:  1991-04       Impact factor: 10.422

4.  Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy.

Authors:  B L Padgett; D L Walker
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

5.  Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals.

Authors:  Y Yogo; T Kitamura; C Sugimoto; T Ueki; Y Aso; K Hara; F Taguchi
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Molecular analysis of JC virus genotypes circulating among the Italian healthy population.

Authors:  Elisabetta Pagani; Serena Delbue; Roberta Mancuso; Elisa Borghi; Letizia Tarantini; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

7.  Human polyomavirus JC virus genome.

Authors:  R J Frisque; G L Bream; M T Cannella
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

8.  Detection of polyomavirus SV40 in tonsils from immunocompetent children.

Authors:  Niraj C Patel; Regis A Vilchez; Deanna E Killen; Preeti Zanwar; Vojtech Sroller; Karen W Eldin; Dolores López-Terrada; Janet S Butel
Journal:  J Clin Virol       Date:  2008-06-09       Impact factor: 3.168

9.  JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy.

Authors:  F A White; M Ishaq; G L Stoner; R J Frisque
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues.

Authors:  P M Chesters; J Heritage; D J McCance
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

View more
  28 in total

Review 1.  Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.

Authors:  A Bellizzi; C Nardis; E Anzivino; D M Rodìo; D Fioriti; M Mischitelli; F Chiarini; V Pietropaolo
Journal:  J Neurovirol       Date:  2012-02       Impact factor: 2.643

Review 2.  Progressive multifocal leukoencephalopathy and newer biological agents.

Authors:  Joseph R Berger
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

3.  JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis.

Authors:  Spyridon Chalkias; Xin Dang; Evelyn Bord; Marion C Stein; R Philip Kinkel; Jacob A Sloane; Maureen Donnelly; Carolina Ionete; Maria K Houtchens; Guy J Buckle; Stephanie Batson; Igor J Koralnik
Journal:  Ann Neurol       Date:  2014-06-10       Impact factor: 10.422

4.  Detection of human polyomavirus proteins, T-antigen and agnoprotein, in human tumor tissue arrays.

Authors:  Luis Del Valle; Kamel Khalili
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

5.  JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy.

Authors:  Chen S Tan; Laura C Ellis; Christian Wüthrich; Long Ngo; Thomas A Broge; Jenny Saint-Aubyn; Janice S Miller; Igor J Koralnik
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

Review 6.  Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.

Authors:  E Tavazzi; P Ferrante; K Khalili
Journal:  Clin Microbiol Infect       Date:  2011-12       Impact factor: 8.067

Review 7.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

8.  Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab.

Authors:  Anna Bellizzi; Elena Anzivino; Federica Ferrari; Giovanni Di Nardo; Maria Teresa Colosimo; Daniela Fioriti; Monica Mischitelli; Fernanda Chiarini; Salvatore Cucchiara; Valeria Pietropaolo
Journal:  J Neurovirol       Date:  2011-05-06       Impact factor: 2.643

9.  JC polyomavirus in the aetiology and pathophysiology of glial tumours.

Authors:  Tihomir Eftimov; Yavor Enchev; Iliya Tsekov; Plamen Simeonov; Zlatko Kalvatchev; Elitsa Encheva
Journal:  Neurosurg Rev       Date:  2015-11-12       Impact factor: 3.042

10.  JC virus T-Antigen DNA in gastrointestinal mucosa of immunosuppressed patients: a prospective, controlled study.

Authors:  Doron Boltin; Alex Vilkin; Zohar Levi; Ori Elkayam; Yaron Niv
Journal:  Dig Dis Sci       Date:  2009-10-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.